Status:
UNKNOWN
Integrating Care for Patients With Alcohol Liver Disease and Alcohol Use Disorders
Lead Sponsor:
University of Manitoba
Conditions:
Alcohol; Liver
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Alcohol related liver disease (ALD) contributes to 50% cases of cirrhosis worldwide and is the leading indication for liver transplant in North America. The treatment for ALD is achieving total alcoho...
Detailed Description
Introduction: Alcohol Use Disorder (AUD) elevates the risk of a number of health conditions, with social, economic and clinical consequences. The effects of AUD are particular evident among individual...
Eligibility Criteria
Inclusion
- Clinical or biopsy-proven alcohol-associated cirrhosis or acute alcoholic hepatitis,
- Active drinking of any amount within the last 6 months,
- Willingness to speak with Addiction Medicine physicians
Exclusion
- Not meeting all inclusion criteria
- Co-morbid severe mental illness
- Medically unstable
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05375682
Start Date
June 1 2022
End Date
June 1 2024
Last Update
May 17 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.